These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3830337)

  • 21. Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs.
    Waddington JL
    Adv Neurol; 1995; 65():211-29. PubMed ID: 7872142
    [No Abstract]   [Full Text] [Related]  

  • 22. Tardive dyskinesia and abnormal tongue movements.
    Pi EH; Simpson GM
    Br J Psychiatry; 1981 Dec; 139():526-8. PubMed ID: 7332858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seven-year follow-up of tardive dyskinesia in Hungarian outpatients.
    Gardos G; Perenyi A; Cole JO; Samu I; Kocsis E; Casey DE
    Neuropsychopharmacology; 1988 May; 1(2):169-72. PubMed ID: 2908016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxypertine in tardive dyskinesia: an 8-week controlled study.
    Soni SD; Freeman HL; Hussein EM
    Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone and naltrexone in mental illness and tardive dyskinesia.
    Volavka J; Anderson B; Koz G
    Ann N Y Acad Sci; 1982; 398():97-102. PubMed ID: 6760771
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical research techniques in tardive dyskinesia.
    Fann WE; Stafford JR; Malone RL; Frost JD; Richman BW
    Am J Psychiatry; 1977 Jul; 134(7):759-62. PubMed ID: 869052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
    Szafrański T
    Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of state-dependent reversal of tardive dyskinesia: phenomenological probe in humans.
    Goswami U; Narayanan HS; Channabasavanna SM
    J Clin Psychopharmacol; 1985 Feb; 5(1):48-50. PubMed ID: 2857733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N; Rondot P; Koutlidis RM
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exacerbation of tardive dyskinesia by Joseph disease.
    Browne JL; Hart RR
    J Clin Psychiatry; 1986 Jun; 47(6):315-6. PubMed ID: 3711030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does tardive dysmentia really exist?
    Lavania S; Praharaj SK; Bains HS; Kumar S; Rathore DM; Mohanty S; Nayak M
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):58-62. PubMed ID: 23487194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dyskinesia workgroup report.
    Kane JM; Schooler NR
    Psychopharmacol Bull; 1980 Jul; 16(3):35-6. PubMed ID: 7403396
    [No Abstract]   [Full Text] [Related]  

  • 34. Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
    Fedorenko OY; Loonen AJ; Lang F; Toshchakova VA; Boyarko EG; Semke AV; Bokhan NA; Govorin NV; Aftanas LI; Ivanova SA
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal gaits in tardive dyskinesia.
    Simpson GM; Shrivastava RK
    Am J Psychiatry; 1978 Jul; 135(7):865. PubMed ID: 665807
    [No Abstract]   [Full Text] [Related]  

  • 36. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of two behavioral treatments in decreasing the orofacial movement of tardive dyskinesia.
    Jackson GM; Schonfeld LI; Griffith K
    Biofeedback Self Regul; 1983 Dec; 8(4):547-53. PubMed ID: 6675730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
    Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Instrumental assessment of lingual motor instability in tardive dyskinesia.
    Caligiuri MP; Jeste DV; Harris MJ
    Neuropsychopharmacology; 1989 Dec; 2(4):309-12. PubMed ID: 2575388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.